Literature DB >> 10818217

Origin of trisomy 21 in Down syndrome cases from a Spanish population registry.

D Gómez1, E Solsona, M Guitart, N Baena, E Gabau, J Egozcue, M R Caballín.   

Abstract

We have carried out a population-based study on the origin of the extra chromosome 21 in 38 families with Down syndrome (DS) offspring in El Vallès (Spain). From 1991 to 1994, a higher prevalence of DS (22.7/10000 live births, stillbirths and induced abortions) was found compared to the majority of EUROCAT registries. The distribution of trisomy 21 by origin was 88% maternal (90.6% meiosis I, 6.2% meiosis II, 3.1% maternal mosaicism), 5.6% paternal (50% meiosis I, 50% meiosis II) and 5.6% mitotic. The percentage of parental mosaicism was 2.7%. These percentages are similar to those previously reported. Recombination study revealed a maternal meiosis I genetic map of 32.68 cM (approximately one-half the length of the normal female map). Mean maternal age among non-recombinant cases involving MI errors was significantly lower (31.1 years) than among those cases showing one observable crossover (36.1 years) (P<0.05); this could support the hypothesis that 'achiasmate' chromosomes may be subject to aberrant segregation regardless of maternal age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818217     DOI: 10.1016/s0003-3995(00)00017-4

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  6 in total

1.  The National Down Syndrome Project: design and implementation.

Authors:  Sallie B Freeman; Emily G Allen; Cindy L Oxford-Wright; Stuart W Tinker; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

2.  Down syndrome: parental origin, recombination, and maternal age.

Authors:  Jadranka Vraneković; Ivana Babić Božović; Zorana Grubić; Jasenka Wagner; Dinko Pavlinić; Sophie Dahoun; Frédérique Bena; Vida Culić; Bojana Brajenović-Milić
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-23

3.  Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects.

Authors:  Emily Graves Allen; Sallie B Freeman; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman
Journal:  Hum Genet       Date:  2008-12-03       Impact factor: 4.132

4.  Association between telomere length and chromosome 21 nondisjunction in the oocyte.

Authors:  I Albizua; B L Rambo-Martin; E G Allen; W He; A S Amin; S L Sherman
Journal:  Hum Genet       Date:  2015-09-25       Impact factor: 4.132

5.  Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project.

Authors:  NaTasha D Hollis; Emily G Allen; Tiffany Renee Oliver; Stuart W Tinker; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Sallie B Freeman; Stephanie L Sherman; Lora J H Bean
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

6.  The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project.

Authors:  Jessica Ezzell Hunter; Emily Graves Allen; Mikyong Shin; Lora J H Bean; Adolfo Correa; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Sallie B Freeman; Stephanie L Sherman
Journal:  Genet Med       Date:  2013-04-04       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.